Mission and Goals
The American Society of Gene Therapy (ASGT) is a professional 501(c)(3) non-profit medical and scientific organization dedicated
to the understanding, development and application of gene and related cell and nucleic acid therapies and the promotion of professional and public education in the field. ASGT is the largest medical professional organization representing researchers and scientists dedicated to discovering new gene and cell therapies. ASGT was established in 1996, and has grown to 2,000 members from around the world. The Society’s goals are to:
Promote Research, Development and Application
Exchange Information and Promote Education Among Professionals and the Public
Promote Development of Clinical Translations
The ASGT 12th Annual Meeting will serve as a comprehensive forum to achieve these goals.
Dates
The ASGT 12th Annual Meeting will begin on the morning of
Wednesday, May 27, 2009, and continue through the evening of
Saturday, May 30, 2009. Exhibits will be open Wednesday, May
27, 2009 through Friday, May 29, 2009.
Needs
Clinical gene transfer has become more and more complex due
to ongoing developments in the fields of gene and cell therapy
itself, together with bioethics, research integrity, and financial
conflicts, as well as federal mandates, regulations and guidelines.
Oligonucleotide Therapies, Novel Vector Development,
Host-Vector Interactions and Vaccine Therapies will be discussed
as well as many other scientific topics. This meeting will provide
an educational forum for scientists and clinicians to expand their
knowledge about the broad developments in these fields.
Educational Objectives
At the conclusion of the activity, the participant should be able to:
Provide advice to patients who inquire about the potential of
gene and cell therapy or the availability of open clinical trials,
based on their exposure to the current clinical trials in gene
and cell therapies.
Better instruct their students in medical school and other
health venues using the state-of-the-art basic science and
clinical trials data presented at the meeting.
Use the latest advances in gene and cell therapy to enhance
their research mission, as physician scientists conducting
basic and clinical research.
Demonstrate improved regulatory compliance in conducting
gene and cell therapy clinical trials, through exposure to NIH
and FDA faculty during the educational program.
Educational Methods and Materials
Lectures; Case Presentations; Panel Discussions; Question and
Answer Sessions; Audio/Video Presentations; Abstracts; Posters.
Materials Distribution
Please refrain from distributing promotional materials.
Target Audience
The target audience includes basic science and translational
researchers, clinical investigators, physicians, postdoctoral fellows,
graduate students, employees of federal government and
regulatory agencies, and other healthcare professionals with an
interest in the latest advancements in the field of gene therapy
and related cell and nucleic acid therapies.
Evaluation Method
Evaluation by questionnaire will address program content, presentation,
and possible bias.
Accreditation Statement
This activity has been planned and implemented in accordance
with the Essential Areas and Policies of the Accreditation Council
for Continuing Medical Education (ACCME) through the joint
sponsorship of Indiana University School of Medicine and the
American Society of Gene Therapy. Indiana University School
of Medicine is accredited by the ACCME to provide continuing
medical education for physicians.
Designation Statement
Indiana University School of Medicine designates this educational
activity for a maximum of 30.75 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent
of their participation in the activity.
Disclosure
In accordance with the Accreditation Council for Continuing
Medical Education (ACCME) Standards for Commercial Support,
educational programs sponsored by Indiana University School
of Medicine (IUSM) must demonstrate balance, independence,
objectivity, and scientific rigor. All faculty, authors, editors, and
planning committee members participating in an IUSM-sponsored
activity are required to disclose any relevant financial
interest or other relationship with the manufacturer(s) of any
commercial product(s) and/or provider(s) of commercial services
that are discussed in an educational activity.
Note
While it offers CME credits, this activity is not intended to provide
extensive training or certification in the field.
Camera/Recording Policy
It is the policy of ASGT that no cameras are permitted in the
meeting sessions, exhibit hall, or poster sessions; except a
professional photographer hired by ASGT. Please refrain from
taking any photos in those locations. Audio and/or videotaping is
strictly prohibited.
Membership
